ST-Line – Next in fusion
Promotional feature With its new ST-Line, SIGNUS has applied the progress from endoprosthetic research to spinal surgery Regardless of the...
Read MoreSuccess of first JASPIS ST® surgery in Australia
Neurosurgeon Dr Andrew Miles, Neurospine Institute, Western Australia successfully completed the first JASPIS® ST surgery in Australia. Dr Miles’ first...
Read MoreMore appealing, more informative and with new functions: the revised SIGNUS website is online
Since the end of August SIGNUS presents itself with a new website. The new online presence offers clearly arranged and...
Read MoreResults of the largest independent randomised controlled trial of a digital therapy against chronic pain
In the largest independent randomised controlled trial (RCT) of its type, a multimodal app-based digital therapy programme for patients with...
Read MoreBiocomposites signs new exclusive distributor in Australia
Biocomposites, an international medical devices company that engineers, manufactures and markets products for use in infection management in bone and...
Read MoreDePuy Synthes extends partnership with AO
DePuy Synthes will continue to work with the AO Foundation to deliver professional education and develop innovations that help improve...
Read MoreOrthoPediatrics Corp launches ApiFix in the US
OrthoPediatrics Corp, a company focused exclusively on the field of paediatric orthopaedics, has launched the ApiFix Minimally Invasive Deformity Correction...
Read MoreInitial Vivex VIA Disc study shows promising potential of injectable treatment option
A non-surgical, injectable treatment option from Vivex for sufferers of chronic lower back pain brought about by degenerative disc disease...
Read More